Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

16.25
Delayed Data
As of May 25
 -0.42 / -2.52%
Today’s Change
5.00
Today|||52-Week Range
51.90
-29.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-11.5M-7.0M-7.8M6.6M
 
 
 
 
 
Depreciation1.4K1.4K2.4K5.1K
 
 
 
 
 
Total Other Cash Flow9.4M1.7M11.7M1.7M
 
 
 
 
 
Funds From Operations-2.1M-5.3M3.8M8.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.1M-1.1M4.8M2.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.0M-4.2M-915.3K5.6M
 
 
 
 
 
 
InvestingCapital Expenditures0.000.00-7.5K0.00
 
 
Net Cash Flow Investing0.000.00-7.5K0.00
 
 
 
FinancingShort Term Borrowings0.00-220.0K-130.0K-165.0K
 
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing661.5K4.6M2.1M0.00
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing661.5K4.4M2.0M-165.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-343.9K179.5K1.0M5.4M